Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Lang, 2016, The pathobiology of chronic thromboembolic pulmonary hypertension, Ann Am Thorac Soc, 13, S215, 10.1513/AnnalsATS.201509-620AS Simonneau, 2017, The pathophysiology of chronic thromboembolic pulmonary hypertension, Eur Respir Rev, 26, 160112, 10.1183/16000617.0112-2016 Kim, 2016, Group 4 pulmonary hypertension: chronic thromboembolic pulmonary hypertension: epidemiology, pathophysiology, and treatment, Cardiol Clin, 34, 435, 10.1016/j.ccl.2016.04.011 Moser, 1993, Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension, Chest, 103, 685, 10.1378/chest.103.3.685 Moser, 1973, Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension, Chest, 64, 29, 10.1378/chest.64.1.29 Dorfmüller, 2014, Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature, Eur Respir J, 44, 1275, 10.1183/09031936.00169113 Galiè, 2016, Eur Heart J, 37, 67, 10.1093/eurheartj/ehv317 Jamieson, 2003, Pulmonary endarterectomy: experience and lessons learned in 1500 cases, Ann Thorac Surg, 76, 1457, 10.1016/S0003-4975(03)00828-2 Delcroix, 2016, Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry, Circulation, 133, 859, 10.1161/CIRCULATIONAHA.115.016522 Pepke-Zaba, 2011, Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry, Circulation, 124, 1973, 10.1161/CIRCULATIONAHA.110.015008 Lang, 2017, Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension, Eur Respir Rev, 26, 160119, 10.1183/16000617.0119-2016 Yi, 2000, Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study, Am J Respir Crit Care Med, 162, 1577, 10.1164/ajrccm.162.4.9912131 Jensen, 2009, Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy, Circulation, 120, 1248, 10.1161/CIRCULATIONAHA.109.865881 Pepke-Zaba, 2017, Medical management of chronic thromboembolic pulmonary hypertension, Eur Respir Rev, 26, 160107, 10.1183/16000617.0107-2016 Ghofrani, 2013, Riociguat for the treatment of chronic thromboembolic pulmonary hypertension, N Engl J Med, 369, 319, 10.1056/NEJMoa1209657 Robbins, 2017, Update on chronic thromboembolic pulmonary hypertension, Trends Cardiovasc Med, 27, 29, 10.1016/j.tcm.2016.05.010 Kim, 2013, Chronic thromboembolic pulmonary hypertension, J Am Coll Cardiol, 62, D92, 10.1016/j.jacc.2013.10.024 Pepke-Zaba, 2013, Chronic thromboembolic pulmonary hypertension: role of medical therapy, Eur Respir J, 41, 985, 10.1183/09031936.00201612 Gatfield, 2012, Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells, PLoS One, 7, e47662, 10.1371/journal.pone.0047662 Pulido, 2013, Macitentan and morbidity and mortality in pulmonary arterial hypertension, N Engl J Med, 369, 809, 10.1056/NEJMoa1213917 Cuzick, 2005, Forest plots and the interpretation of subgroups, Lancet, 365, 1308, 10.1016/S0140-6736(05)61026-4 Mayer, 2011, Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry, J Thorac Cardiovasc Surg, 141, 702, 10.1016/j.jtcvs.2010.11.024 Auger, 2012, Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy, Pulm Circ, 2, 155, 10.4103/2045-8932.97594 Cannon, 2016, Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort, Circulation, 133, 1761, 10.1161/CIRCULATIONAHA.115.019470 Jäis, 2008, Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial, J Am Coll Cardiol, 52, 2127, 10.1016/j.jacc.2008.08.059 Suntharalingam, 2008, Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension, Chest, 134, 229, 10.1378/chest.07-2681 Olschewski, 2002, Inhaled iloprost for severe pulmonary hypertension, N Engl J Med, 347, 322, 10.1056/NEJMoa020204 Matsuda, 2006, Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension, Ann Thorac Surg, 82, 1338, 10.1016/j.athoracsur.2006.03.105 Simonneau, 2016, Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial, Lancet Respir Med, 4, 372, 10.1016/S2213-2600(16)30022-4 Reesink, 2007, Embolization for hemoptysis in chronic thromboembolic pulmonary hypertension: report of two cases and a review of the literature, Cardiovasc Intervent Radiol, 30, 136, 10.1007/s00270-005-0382-8